Skip to main content

Table 3 Laboratory data of cases of eosinophilic abscesses and malignant nodules

From: Clinical characteristics that distinguish eosinophilic organ infiltration from metastatic nodule development in cancer patients with eosinophilia

Characteristics Eosinophilic abscess group (n = 33) Malignant nodule group (n = 5) P-value
Blood eosinophils, number/ul 1,808.6 ± 1,625.8 4,186 ± 4,053.7 0.160
Blood eosinophils, % 20.0 ± 11.2 31.6 ± 21.0 0.243
Severity of eosinophilia,    0.060
 Mild (450–1,500/ul) 52 (17/33) 40 (2/5)  
 Moderate (1,500–5,000/ul) 45 (15/33) 20 (1/5)
 Severe (5,000–/ul) 3 (1/33) 40 (2/5)
Duration of eosinophilia, months 10.5 ± 9.8   
Log total IgE 7.4 ± 1.4 4.9 ± 1.2 0.021
AST, IU/l 26.6 ± 12.9 112.60 ± 100.0 0.002
ALT, IU/l 22.7 ± 18.7 80.0 ± 47.4 0.002
Alkaline phosphatase, IU/l 76.4 ± 23.1 460.0 ± 509.8 0.019
Bilirubin, total, mg/dl 0.9 ± 0.4 5.2 ± 8.3 0.002
C-reactive protein, mg/dl 0.8 ± 0.9 10.8 ± 12.8 0.004
Erythrocyte sedimentation rate, mm/h 31.3 ± 19.1 102.5 ± 24.8 0.040
  1. The data are presented as means ± SD or number (%).
  2. The P-values are determined by the Mann-Whitney U-test, chi-square or Fisher’s test.